3.3 AND/ASPEN & GLIM Malnutrition Criteria

3.3 AND/ASPEN & GLIM Malnutrition Criteria

Quick Answer: The clinical diagnosis of adult malnutrition relies on standardized, etiology-driven frameworks rather than serum visceral proteins. The 2012 Academy of Nutrition and Dietetics/ASPEN consensus requires at least 2 of 6 standardized clinical characteristics (intake deficit, weight loss, muscle loss, fat loss, fluid accumulation, reduced grip strength) evaluated across three distinct inflammatory contexts (acute illness, chronic illness, social/starvation). In contrast, the 2019 Global Leadership Initiative on Malnutrition (GLIM) consensus enforces a two-step framework requiring at least 1 phenotypic criterion (weight loss, low BMI, reduced muscle mass) combined with at least 1 etiologic criterion (reduced intake/assimilation, disease burden/inflammation), with severity graded exclusively by phenotypic thresholds.

---

The Demise of Visceral Proteins as Nutritional Markers

For decades, clinical medicine relied on serum visceral proteins—principally albumin (half-life $t_{1/2} \approx 20\text{ days}$) and prealbumin (also known as transthyretin, $t_{1/2} \approx 2\text{ days}$)—to diagnose protein-calorie malnutrition and monitor feeding efficacy. Modern nutritional science and critical care guidelines have definitively rejected this paradigm.

The Pathophysiology of the Inflammatory Response

Albumin and prealbumin are negative acute-phase reactants synthesized by hepatocytes. In the presence of acute or chronic systemic inflammation (triggered by trauma, infection, sepsis, surgery, burns, or advanced chronic organ disease), proinflammatory cytokines—predominantly Interleukin-6 (IL-6), Interleukin-1 (IL-1), and Tumor Necrosis Factor-alpha (TNF-$\alpha$)—alter hepatic gene transcription:

Proinflammatory Cytokines (IL-6, IL-1, TNF-alpha)
   │
   ├── Downregulate Hepatic Synthesis ──> Negative Acute-Phase Reactants (Albumin, Prealbumin, Transferrin)
   │
   └── Upregulate Hepatic Synthesis   ──> Positive Acute-Phase Reactants (C-Reactive Protein [CRP], Ferritin, Fibrinogen)

1. Hepatic Reprioritization: The liver dramatically downregulates the synthesis of albumin and prealbumin to prioritize the production of positive acute-phase reactants necessary for host defense and wound repair, including C-Reactive Protein (CRP), ferritin, fibrinogen, and serum amyloid A.
2. Capillary Leak and Extravasation: Systemic inflammatory mediators induce vascular endothelial junction breakdown. Albumin rapidly extravasates from the intravascular space into the interstitial compartment (third-spacing), drastically lowering measured serum concentrations within hours.
3. Expansion of Distribution Volume: Aggressive crystalloid fluid resuscitation expands intravascular plasma volume, further diluting circulating protein concentrations.

Clinical Consensus

Serum albumin and prealbumin are potent biomarkers of inflammatory severity and systemic morbidity; a low serum prealbumin accurately predicts poor clinical outcomes, extended hospital length of stay, and heightened mortality. However, visceral proteins do not reflect somatic protein stores, total body nitrogen balance, or dietary intake adequacy.

A patient with severe septic shock and multi-organ failure may exhibit a serum albumin of $1.8\text{ g/dL}$ despite receiving optimal enteral nutrition, while a patient with pure marasmic starvation may maintain a completely normal serum albumin of $4.0\text{ g/dL}$ while losing $25\%$ of their skeletal muscle mass. Nutrition support clinicians must never use visceral proteins in isolation to diagnose malnutrition or titrate feeding regimens.

---

The 2012 AND/ASPEN Malnutrition Consensus Framework

In 2012, the Academy of Nutrition and Dietetics (AND) and the American Society for Parenteral and Enteral Nutrition (ASPEN) published a landmark consensus statement establishing an etiology-based framework that classifies adult malnutrition according to the presence and degree of systemic inflammation.

Three Etiology-Based Clinical Contexts

1. Malnutrition in the Context of Acute Illness or Injury:
   • Driven by marked, severe systemic inflammatory response.
   • Clinical examples: Severe sepsis, major polytrauma, full-thickness burns ($>20\%$ TBSA), acute respiratory distress syndrome (ARDS), severe acute necrotizing pancreatitis, major surgical complications.
   • Metabolic hallmarks: Rapid onset, marked hypermetabolism, rapid proteolysis, acute insulin resistance.
2. Malnutrition in the Context of Chronic Illness:
   • Driven by sustained mild-to-moderate systemic inflammation lasting $\ge 3\text{ months}$.
   • Clinical examples: Congestive heart failure (cardiac cachexia), chronic obstructive pulmonary disease (pulmonary cachexia), end-stage renal disease (ESRD), cirrhosis, active malignant neoplasms, rheumatoid arthritis, Crohn's disease.
   • Metabolic hallmarks: Insidious, progressive wasting of both skeletal muscle and adipose reserves over months.
3. Malnutrition in the Context of Social or Environmental Circumstances (Non-Illness / Starvation):
   • Characterized by the absence of systemic inflammation.
   • Clinical examples: Pure starvation, anorexia nervosa, major depressive disorder with severe anorexia, severe poverty, food insecurity, isolated elder neglect.
   • Metabolic hallmarks: Pure energy deficit (classic marasmus); basal metabolic rate downregulates, ketogenesis preserves somatic protein longer.

The Six Standardized Diagnostic Characteristics

To establish a clinical diagnosis of malnutrition under AND/ASPEN, the clinician must document at least two of the following six characteristics:

1. Insufficient energy intake
2. Involuntary weight loss over time
3. Loss of skeletal muscle mass (identified via NFPE)
4. Loss of subcutaneous fat (identified via NFPE)
5. Localized or generalized fluid accumulation / edema (identified via NFPE)
6. Measurably diminished functional status (measured via handgrip dynamometry)

Complete AND/ASPEN Diagnostic Matrix Table

Diagnostic Requirement: Meeting at least two criteria within a given severity row confirms the diagnosis of moderate or severe malnutrition for that clinical context.

---

The 2019 Global Leadership Initiative on Malnutrition (GLIM) Framework

In 2019, the major global clinical nutrition societies—ASPEN, the European Society for Clinical Nutrition and Metabolism (ESPEN), the Latin American Federation of Nutritional Therapy, Clinical Nutrition and Metabolism (FELANPE), and the Parenteral and Enteral Nutrition Society of Asia (PENSA)—formed the Global Leadership Initiative on Malnutrition (GLIM) to build a universal diagnostic framework.

The Two-Step Diagnostic Paradigm

Step 1: Universal Nutrition Risk Screening
   └─ Utilizes validated screening tools (MUST, NRS-2002, MST, MNA-SF)
   └─ If positive (at-risk) ──> Proceed to Step 2

Step 2: Diagnostic Assessment & Severity Grading
   ├─ Requires: ≥ 1 Phenotypic Criterion  AND  ≥ 1 Etiologic Criterion
   └─ Grade Severity: Stage 1 (Moderate) vs Stage 2 (Severe) via Phenotypic thresholds

GLIM Diagnostic Criteria

A confirmed diagnosis of malnutrition under GLIM mandates the presence of at least one Phenotypic criterion AND at least one Etiologic criterion.

Three Phenotypic Criteria (Physical Manifestations)

1. Involuntary / Non-volitional Weight Loss:
   • $> 5\%$ weight loss within the past 6 months, OR
   • $> 10\%$ weight loss beyond 6 months.
2. Low Body Mass Index (BMI):
   • Age $< 70\text{ years}$: $< 20.0\text{ kg/m}^2$ (or $< 18.5\text{ kg/m}^2$ in Asian populations).
   • Age $\ge 70\text{ years}$: $< 22.0\text{ kg/m}^2$ (or $< 20.0\text{ kg/m}^2$ in Asian populations).
3. Reduced Muscle Mass:
   • Quantified by validated body composition technologies or anthropometry:
     • Dual-Energy X-ray Absorptiometry (DXA): Appendicular lean mass index (ALMI) $< 7.0\text{ kg/m}^2$ for men, $< 5.5\text{ kg/m}^2$ for women.
     • Bioelectrical Impedance Analysis (BIA): Fat-free mass index (FFMI) $< 17.0\text{ kg/m}^2$ for men, $< 15.0\text{ kg/m}^2$ for women.
     • Computed Tomography (CT): Skeletal muscle index at L3 lumbar level (SMI $< 55\text{ cm}^2\text{/m}^2$ for men, $< 39\text{ cm}^2\text{/m}^2$ for women).
     • Bedside Physical Examination / Surrogates: Calf circumference $< 31\text{ cm}$, or physical examination muscle wasting (NFPE) when body composition equipment is unavailable.

Two Etiologic Criteria (Causal Mechanisms)

1. Reduced Food Intake or Assimilation:
   • Food intake reduction: $\le 50\%$ of energy requirement for $> 1\text{ week}$, or any reduction for $> 2\text{ weeks}$.
   • Gastrointestinal condition / malabsorption: Chronic malabsorption, short bowel syndrome, pancreatic exocrine insufficiency, high-output enterocutaneous fistulae, gastrectomy, bariatric malabsorption, severe dysphagia, intractable nausea/vomiting.
2. Disease Burden / Inflammation:
   • Acute disease / injury: Severe sepsis, pneumonia, ARDS, polytrauma, major burns, major surgery, intensive care admission.
   • Chronic organ disease: Congestive heart failure, COPD, cirrhosis, active cancer, chronic kidney disease (CKD stage 4–5), chronic systemic autoimmune diseases.
   • Biochemical confirmation: Elevated serum C-Reactive Protein (CRP) provides objective verification of systemic inflammation.

GLIM Severity Grading Matrix

Once a diagnosis is established ($\ge 1\text{ phenotypic} + \ge 1\text{ etiologic}$), severity is determined exclusively by the magnitude of the phenotypic criteria:

Rule for Severity: If a patient fulfills criteria across different tiers (e.g., moderate weight loss but severe low BMI), the most severe phenotypic criterion dictates the overall diagnosis (Stage 2 Severe).

---

Comparative Clinical Synthesis: AND/ASPEN vs. GLIM

---

Clinical Documentation Improvement (CDI) & Coding Integrity

Accurate malnutrition documentation directly impacts patient safety, hospital quality metrics, risk-adjusted mortality models, and healthcare reimbursement:

• Comorbidity and Complication Status: Under Medicare Severity Diagnosis Related Groups (MS-DRGs), malnutrition represents a Major Complication or Comorbidity (MCC) or Complication or Comorbidity (CC), reflecting the substantially higher resource utilization and nursing care required.
• Physician Query Requirements: Registered Dietitian Nutritionists (RDNs) and nutrition support clinicians document the NFPE and diagnostic criteria; however, the treating physician or advanced practice provider (APRN/PA) must explicitly document the diagnosis in their clinical progress notes or discharge summary.
• ICD-10 Coding Alignment:
  • E43: Unspecified severe protein-calorie malnutrition (MCC)
  • E44.0: Moderate protein-calorie malnutrition (CC)
  • E44.1: Mild protein-calorie malnutrition
  • E46: Unspecified protein-calorie malnutrition

To withstand auditor review, clinical notes must document: (1) the specific clinical context and etiology, (2) at least two objective criteria with quantitative data (e.g., exact percent weight loss over timeframe, specific NFPE anatomic wasting sites), (3) the resulting diagnosis (moderate or severe), and (4) an actionable nutrition support intervention plan.

---

Independent Prep Note

This independent study resource from OpenExamPrep is designed to provide comprehensive, evidence-based preparation for clinical nutrition support examinations. It is not affiliated with, sponsored by, or endorsed by the National Board of Nutrition Support Certification (NBNSC) or ASPEN.